BAMF
TMO icon

BI Asset Management Fondsmaeglerselskab’s Thermo Fisher Scientific TMO Stock Holding History

BI Asset Management Fondsmaeglerselskab’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.2M Buy
75,918
+12,304
+19% +$5.91M 0.29% 63
2026
Q1 		$27.8M Sell
63,614
-47,689
-43% -$25.9M 0.29% 61
2025
Q4 		$61.9M Buy
111,303
+3,365
+3% +$1.9M 0.55% 31
2025
Q3 		$49.7M Buy
107,938
+42,724
+66% +$19.9M 0.45% 46
2025
Q2 		$26.4M Buy
65,214
+326
+0.5% +$136K 0.26% 83
2025
Q1 		$32.3M Buy
64,888
+2,272
+4% +$1.23M 0.36% 58
2024
Q4 		$32.6M Buy
62,616
+50,015
+397% +$27.5M 0.34% 58
2024
Q3 		$7.79M Sell
12,601
-2,184
-15% -$1.29M 0.14% 139
2024
Q2 		$8.18M Buy
14,785
+3,305
+29% +$1.89M 0.13% 147
2024
Q1 		$6.67M Buy
11,480
+2,234
+24% +$1.25M 0.13% 143
2023
Q4 		$4.91M Sell
9,246
-3,786
-29% -$1.83M 0.1% 168
2023
Q3 		$6.6M Sell
13,032
-37,978
-74% -$20.2M 0.15% 122
2023
Q2 		$26.6M Buy
51,010
+2,798
+6% +$1.51M 0.63% 41
2023
Q1 		$27.8M Sell
48,212
-9,217
-16% -$5.19M 0.74% 34
2022
Q4 		$31.6M Buy
57,429
+54,493
+1,856% +$28.9M 0.84% 27
2022
Q3 		$1.49M Sell
2,936
-1,681
-36% -$941K 0.08% 153
2022
Q2 		$2.51M Buy
+4,617
New +$2.54M 0.11% 136
2022
Q1 		– Sell
-604
Closed -$403K – 521
2021
Q4 		$403K Buy
+604
New +$377K 0.01% 344
2021
Q3 		– Sell
-38,246
Closed -$19.3M – 402
2021
Q2 		$19.3M Buy
38,246
+5,086
+15% +$2.4M 0.74% 41
2021
Q1 		$15.1M Buy
33,160
+20,150
+155% +$9.62M 0.62% 52
2020
Q4 		$6.06M Buy
13,010
+11,943
+1,119% +$5.6M 0.26% 88
2020
Q3 		$471K Buy
+1,067
New +$441K 0.02% 363

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab's TMO Position: Q2 2026 in Review

BI Asset Management Fondsmaeglerselskab increased its Thermo Fisher Scientific (TMO) stake by 19% in Q2 2026, buying an estimated $5.91M and bringing the position to 75,918 shares worth $36.2M. The position accounts for 0.29% of the portfolio, ranked #63.

BI Asset Management Fondsmaeglerselskab first reported a position in TMO in Q3 2020 and has held it in 22 quarters since. The position peaked at $61.9M in Q4 2025. 2,604 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • BI Asset Management Fondsmaeglerselskab held 75,918 shares of Thermo Fisher Scientific worth $36.2M as of Q2 2026.
  • BI Asset Management Fondsmaeglerselskab bought 12,304 Thermo Fisher Scientific shares in Q2 2026, an estimated $5.91M.
  • Thermo Fisher Scientific made up 0.29% of BI Asset Management Fondsmaeglerselskab's portfolio in Q2 2026, its #63 holding.
  • BI Asset Management Fondsmaeglerselskab first reported a position in Thermo Fisher Scientific in Q3 2020 and has held it in 22 quarters since.
  • BI Asset Management Fondsmaeglerselskab's Thermo Fisher Scientific position peaked at $61.9M in Q4 2025.
  • 2,604 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2026, filed 10 Aug 2026.